SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
SmartTRAK spoke with the Westbrook Weaver, CEO of Tempo Therapeutics, to discuss the company’s new techn...
The North American Neuromodulation Society (NANS) is once again bringing together the leading clinicians...
Chance Leonard and R. Sean Churchill, MD, MBA, of Genesis Innovation Group and Capitan Orthopedics, disc...
The Musculoskeletal New Ventures Conference meeting offers a glimpse into emerging and promising technol...
This SmartTRAK interview features a panel of experts discussing the clinical shift in hip preservation t...
The high costs and complexity involved in manual manufacturing hinder the commercial viability of regene...
Dr. Silverman discusses key takeaways from the AOFAS meeting, along with insights into his practice's sh...
Wound GM Kris Flinn and Senior Analysts Elizabeth Anderson and Jay Merkel discuss the impact of the fina...
Leo Smit, CEO of Hy2Care, discusses the company's innovative hydrogel platform for articular cartilage r...
Conmed’s Lisa Donnelly, VP of Marketing for US Orthopedics, and Jeff Ott, Director of R&D, discuss t...
Login